366 related articles for article (PubMed ID: 31387311)
21. The orchestrating role of deteriorating neurons and TREM-1 in crosstalk with SYK in Alzheimer's disease progression and neuroinflammation.
Anwar MM
Inflammopharmacology; 2023 Oct; 31(5):2303-2310. PubMed ID: 37405587
[TBL] [Abstract][Full Text] [Related]
22. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
23. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
[TBL] [Abstract][Full Text] [Related]
24. TREM1 facilitates microglial phagocytosis of amyloid beta.
Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT
Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763
[TBL] [Abstract][Full Text] [Related]
25. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease.
Park J; Wetzel I; Marriott I; Dréau D; D'Avanzo C; Kim DY; Tanzi RE; Cho H
Nat Neurosci; 2018 Jul; 21(7):941-951. PubMed ID: 29950669
[TBL] [Abstract][Full Text] [Related]
26. Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.
Lue LF; Walker DG; Rogers J
Neurobiol Aging; 2001; 22(6):945-56. PubMed ID: 11755003
[TBL] [Abstract][Full Text] [Related]
27. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
[TBL] [Abstract][Full Text] [Related]
28. Deletion of Alzheimer's disease-associated CD33 results in an inflammatory human microglia phenotype.
Wißfeld J; Nozaki I; Mathews M; Raschka T; Ebeling C; Hornung V; Brüstle O; Neumann H
Glia; 2021 Jun; 69(6):1393-1412. PubMed ID: 33539598
[TBL] [Abstract][Full Text] [Related]
29. Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.
Mendsaikhan A; Tooyama I; Walker DG
Cells; 2019 Mar; 8(3):. PubMed ID: 30862089
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory mechanisms in neurodegeneration.
Nichols MR; St-Pierre MK; Wendeln AC; Makoni NJ; Gouwens LK; Garrad EC; Sohrabi M; Neher JJ; Tremblay ME; Combs CK
J Neurochem; 2019 Jun; 149(5):562-581. PubMed ID: 30702751
[TBL] [Abstract][Full Text] [Related]
31. New insights into the role of TREM2 in Alzheimer's disease.
Gratuze M; Leyns CEG; Holtzman DM
Mol Neurodegener; 2018 Dec; 13(1):66. PubMed ID: 30572908
[TBL] [Abstract][Full Text] [Related]
32. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
[TBL] [Abstract][Full Text] [Related]
33. IRF-8 is Involved in Amyloid-β
Zeng Q; Man R; Luo Y; Zeng L; Zhong Y; Lu B; Wang X
J Mol Neurosci; 2017 Oct; 63(2):159-164. PubMed ID: 28856571
[TBL] [Abstract][Full Text] [Related]
34. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
35. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
36. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
[TBL] [Abstract][Full Text] [Related]
37. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
[TBL] [Abstract][Full Text] [Related]
38. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Dong Y; Li X; Cheng J; Hou L
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696107
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo.
Kim HG; Kim JY; Whang WW; Oh MS
Can J Physiol Pharmacol; 2014 Jun; 92(6):429-37. PubMed ID: 24820962
[TBL] [Abstract][Full Text] [Related]
40. The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease.
Salminen A; Kaarniranta K; Kauppinen A
Cell Mol Life Sci; 2018 Sep; 75(17):3099-3120. PubMed ID: 29779041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
